An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

NCT03348046 ·Status: COMPLETED

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

NCT02659150 ·Status: TERMINATED ·Phase: PHASE4

An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01375478 ·Status: COMPLETED

An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab

NCT02507752 ·Status: COMPLETED

A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)

NCT01292265 ·Status: TERMINATED ·Phase: PHASE3

A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis

NCT00281294 ·Status: TERMINATED ·Phase: PHASE2

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

NCT01649817 ·Status: COMPLETED

Observation of Treatment With Certolizumab Pegol in Daily Practice

NCT01069419 ·Status: COMPLETED

Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT02101307 ·Status: COMPLETED

Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

NCT03535402 ·Status: UNKNOWN ·Phase: PHASE3

Rituximab in Rheumatoid Arthritis Lung Disease

NCT00578565 ·Status: COMPLETED ·Phase: PHASE3

Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

NCT01752855 ·Status: COMPLETED ·Phase: PHASE2

An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective

NCT02566967 ·Status: COMPLETED ·Phase: PHASE3

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis

NCT01952509 ·Status: COMPLETED

Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

NCT01235598 ·Status: COMPLETED ·Phase: PHASE3

Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept

NCT02353780 ·Status: TERMINATED ·Phase: PHASE4

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

NCT02795299 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate

NCT00266227 ·Status: COMPLETED ·Phase: PHASE3

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

NCT01021735 ·Status: COMPLETED ·Phase: PHASE4

A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)

NCT01893255 ·Status: WITHDRAWN

A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)

NCT00202852 ·Status: COMPLETED ·Phase: PHASE3

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

NCT00425932 ·Status: COMPLETED ·Phase: PHASE2

Tocilizumab REMission in Early RA

NCT04157010 ·Status: COMPLETED ·Phase: PHASE4

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

NCT05424926 ·Status: COMPLETED